Medical Management of Asymptomatic Carotid Artery Stenosis

Area of Science:

• Cardiovascular Medicine
• Neurology
• Vascular Surgery

Background:

• Carotid artery atherosclerosis, leading to carotid artery stenosis (CAS), is a significant risk factor for stroke and cardiovascular disease.
• The optimal management strategy for asymptomatic patients with CAS is not well-defined.
• Current guidelines for revascularization in severe CAS were established before the widespread adoption of today's optimal medical therapy (OMT).

Purpose of the Study:

• To review the risk factors associated with CAS and stroke.
• To evaluate the evidence supporting each component of OMT for patients with asymptomatic CAS.
• To inform clinical decision-making regarding the management of asymptomatic CAS.

Main Methods:

• Literature review of randomized clinical trials and observational studies.
• Analysis of data on risk factors for CAS and stroke.
• Examination of the efficacy of individual components of OMT in managing CAS.

Main Results:

• Optimal medical therapy (OMT) alone may offer substantial stroke risk reduction in many patients with asymptomatic CAS.
• The benefits of revascularization (endarterectomy or stenting) in trials predating modern OMT may be overestimated.
• Individual components of OMT, including statins, antihypertensives, and antiplatelet agents, play a crucial role in risk mitigation.

Conclusions:

• OMT is a cornerstone in managing asymptomatic carotid artery stenosis (CAS), potentially reducing the need for invasive procedures.
• Further research is needed to precisely define the role of revascularization versus OMT in specific patient subgroups.
• Aggressive medical management should be considered the primary approach for many individuals with asymptomatic CAS due to its favorable risk-benefit profile.